Authors
Latest:
Advocacy and Empowerment: Finding Your Advocacy CommunityThe Palatucci Advocacy Leadership Forum, or PALF, sponsored by the American Academy of Neurology, gives neurologists and trainees tools to successfully advocate for their ideas and develop their identity as physician advocates.
Latest:
Management of Amyloid Related Imaging Abnormalities (ARIA) for Alzheimer’s DiseaseDr Atri comments on observation of amyloid related imaging abnormalities (ARIA) seen with many Alzheimer’s disease treatments and shares his thoughts on management of ARIA.
Latest:
Early Awareness Towards Epilepsy TransitionSucheta M. Joshi, MD, MS, FAES, FAAP, and Nicholas Beimer, MD, discussed the reasons why EpiTRAQ may influence earlier discussions with patients prior to the epilepsy transition process.
Latest:
R&D for NMOSD TherapiesDrs Mirla Avila, Mitzi Williams, Michael Levy, and Michael Yeaman comment on research and development priorities for clinical care and emerging therapies for NMOSD.
Latest:
Achieving Greater Diversity in Dementia Research: A Call to ActionAchieving greater diversity in study populations is a focus of increasing scrutiny, priority, and funding in all medical research, including studies enrolling individuals on the continuum of prodromal Alzheimer disease, mild cognitive impairment, and Alzheimer disease.
Latest:
Managing Insomnia: Practical Advice for Community PhysiciansClosing their discussion on insomnia, panelists share final thoughts and advice for community physicians.
Latest:
Future Thoughts and Reason for Excitement in ALS: Timothy Miller, MD, PhDThe codirector of the ALS Center at Washington University School of Medicine detailed the reasons for hope within the ALS space and the promising innovations in the coming future. [WATCH TIME: 4 minutes]
Latest:
AUPN Leadership Minute Episode 9: Engaging Medical Students in Neurology – Part 2Episode 9 of the AUPN Leadership Minute features Donald S. Higgins, Jr., MD, of the Veterans Health Administration; and Douglas J. Gelb, MD, PhD, of the University of Michigan [WATCH TIME: 5 minutes]
Latest:
Future of Treating DMDFinal thoughts from leading experts on the future of treating Duchenne muscular dystrophy and keeping standard of care in the forefront.
Latest:
Connections Between Migraine and Mental Health: Lawrence Newman, MDThe chair of the American Migraine Foundation spoke about the insight gleaned from a recent survey the foundation conducted assessing links between mental health and migraine care. [WATCH TIME: 4 minutes]
Latest:
Future of Relapsing MS ManagementKey opinion leaders in multiple sclerosis (MS) discuss the future of relapsing MS management and unmet needs.
Latest:
Understanding Disadvantages to African Americans in NMOSD Trials: Evanthia Bernitsas, MDThe neurologist at Wayne State University provided background on why there needs to be a continued focus on including and studying African American patients with NMOSD in trials. [WATCH TIME 3 minutes]
Latest:
The State of Multiple Sclerosis Therapy and Trends in Thinking: Robert K. Shin, MDThe professor of neurology at MedStar Georgetown University Hospital shared his perspective on the trends in thinking about the treatment of MS and how an improved understanding of underlying processes has led to a shift in the field. [WATCH TIME: 5 minutes]
Latest:
State of Mental Health Care for Patients With MS: Dawn Edhe, PhDThe psychologist and professor in the department of rehabilitation medicine at the University of Washington shared her perspective on the state of mental health care in multiple sclerosis. [WATCH TIME: 4 minutes]
Latest:
Questions of Adherence Raised by Unused Multiple Sclerosis Disease-Modifying Therapies: Darin T. Okuda, MD; Karin CookThe coauthors of a study assessing costs associated with unused disease-modifying therapies shared their insight into the extended effects of unused treatments in MS, including the importance of transparency between physician and patient. [WATCH TIME: 12 minutes]
Latest:
Need for Increased Multidisciplinary Study of Newborn and Infant Sleep in Epilepsy: Renee Shellhaas, MD, MS, FAESThe professor of neurology at Washington University School of Medicine in St. Louis spoke about the field of newborn sleep and epilepsy based on a special lecture from the 2022 AES annual meeting. [WATCH TIME: 3 minutes]
Latest:
Exponential Growth of Research, Biomarkers in Alzheimer Disease: Thomas Wisniewski, MDThe director of NYU Langone’s Alzheimer’s Disease Research Center discussed noticeable advancements within the field of Alzheimer disease in recent years and how they contribute to gaining a better understanding of the disease. [WATCH TIME: 5 minutes]
Latest:
Differentiating Tardive Dyskinesia From Similar Drug-Induced Movement DisordersTardive dyskinesia can present many challenges in its treatment and can be difficult to differentiate from similar disorders.
Latest:
Assessing, Validating Clinically Relevant Biomarkers for Alzheimer Disease: Jefferson Kinney, PhDThe founding chair of the department of brain health at the University of Nevada Las Vegas discussed the plethora of Alzheimer disease biomarkers and the need for consensus on the value of each. [WATCH TIME: 3 minutes]
Latest:
AUPN 2022 Women Leaders in NeurologyLaurie Gutmann, MD; Gauri Pawar, MD; and Claire Henchcliffe, MD, discuss their own paths in medicine and observations of other women leaders. [WATCH TIME: 1 hour, 51 minutes]
Latest:
Key Takeaways for Treating OFF Episodes in PDDrs Laxman Bahroo, Rajesh Pahwa, and Robert A. Hauser share advice for neurologists treating OFF episodes in Parkinson Disease.
Latest:
Stanford Children’s Health: A Comprehensive Approach to Care for a Child With a Neurological ConditionPhysicians from Stanford Children’s Health offer their keys to successful pediatric neuroscience teams and what to focus on to provide a better quality of life for children.
Latest:
Roundtable: The Future of Stereotactic and Functional NeurosurgeryTwo experts at Jefferson Health discuss several topics related to advances in neurosurgery, technology, and the future of minimally invasive procedures.
Latest:
Future of Treating DMDFinal thoughts from leading experts on the future of treating Duchenne muscular dystrophy and keeping standard of care in the forefront.
Latest:
Ideal Patient Profiles for Spinal Muscular Atrophy Therapies / Perfis ideais de pacientes para tratamento da atrofia muscular espinhalThe expert panel comments on ideal patient profiles for SMA treatment with nusinersen, onasemnogene abeparvovec, and risdiplam. O painel de especialistas comenta os perfis ideais de pacientes para tratamento da atrofia muscular espinhal com nusinersena, onasemnogeno abeparvoveque e risdiplam.
Latest:
Exploring Deep Brain Stimulation’s Effects in Alzheimer Disease: Donald Whiting, MDThe chair of Allegheny Health Network’s Neurosciences Institute discussed a groundbreaking phase 3 trial evaluating the safety and efficacy of deep brain stimulation in patients with Alzheimer disease. [WATCH TIME: 5 minutes]
Latest:
Expanding the Use of Spinal Cord Atrophy in Multiple Sclerosis: Blake E. Dewey, PhDThe postdoctoral researcher at the Johns Hopkins Multiple Sclerosis Center shared his perspective on the use of spinal cord atrophy in clinical practice to measure disease progression in MS and how it might become more accessible. [WATCH TIME: 4 minutes]
Latest:
Taking the Leap: Forging Your Own Path as a Woman in MedicineTheresa Sevilis, DO, writes on picking a career path in medicine as a woman, and how deciding to jump ship from a traditional path was among the best decisions she's made.
Latest:
2022 SMA Research & Clinical Care Meeting: What to ExpectMary Schroth, MD, and Jacqueline Glascock, PhD, of Cure SMA, share their perspectives on the upcoming annual meeting.
Latest:
Future Directions in Research and TreatmentLooking to the future of multiple sclerosis care, the panel of thought leaders pose important questions that remain to be answered in the research and treatment of multiple sclerosis.
